High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma
- 1 July 1989
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Chemotherapy and Pharmacology
- Vol. 24 (1), S40-S44
- https://doi.org/10.1007/bf00253239
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescentsZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Die kooperative Ewing-Sarkom-Studie CESS 81 der GPO - Analyse nach 4 Jahren*+(*Klinische Padiatrie, 1985
- The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcomaEuropean Journal of Cancer and Clinical Oncology, 1985
- High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaCancer Chemotherapy and Pharmacology, 1983
- Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomasCancer Treatment Reviews, 1983
- High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trialCancer Treatment Reviews, 1983
- Ifosfamide, mesna and vincristine in paediatric oncologyCancer Treatment Reviews, 1983
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—I: Experimental studies on the urotoxicity of alkylating compoundsEuropean Journal of Cancer (1965), 1981
- Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study.1981
- Curability of ewing's sarcoma and considerations for future therapeutic trialsCancer, 1978